I G 225 (Gemfibrozil 600 mg)
Pill imprint I G 225 has been identified as Gemfibrozil 600 mg.
Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Gemfibrozil 600 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for I G 225 (Gemfibrozil 600 mg)
- 600 mg
- 19.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Major Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium stearate
silicon dioxide colloidal
methylcellulose (100 mPa.s)
|NDC Code||Manufacturer / Repackager|
|31722-0225||Camber Pharmaceuticals Inc|
|68084-0473||Amerisource Health Services|
|24658-0130||Blu Pharmaceuticals LLC|
|67544-1111||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
Gemfibrozil is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...